Zylox-Tonbridge Medical Technology Co., Ltd.

HKEX:2190.HK

10.92 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 34.43334.433-21.61-21.61-17.757-17.757-44.026-44.026-12.752-12.752-64.986-64.986-34.859-34.859-32.834-32.834-17.4-17.4
Depreciation & Amortization 9.049.049.7569.7568.1858.1857.4547.4545.6815.6813.8693.8692.8222.8222.3912.3912.4282.428
Deferred Income Tax 000000-28.024.5070000000000
Stock Based Compensation 4.6534.65327.88827.88814.99614.99626.76726.76717.07317.07326.87826.87811.22811.22811.18211.1820.3740.374
Change In Working Capital 00-1.806-1.80600-54.65-54.6500-20.858-20.85800-12.866-12.86600
Accounts Receivables 00-0.085-0.08500-0.287-0.28700-0.165-0.165000.4420.44200
Change In Inventory 00-23.649-23.64900-30.986-30.98600-14.14-14.1400-9.519-9.51900
Change In Accounts Payables 000000000000000000
Other Working Capital 0021.92921.92900-23.377-23.37700-6.554-6.55400-3.789-3.78900
Other Non Cash Items 3.8913.89144.25444.254-14.685-14.68543.87743.877-35.084-35.08419.32919.329-1.526-1.5265.5485.5480.0110.011
Operating Cash Flow 52.01652.01658.48258.482-9.262-9.262-20.579-20.579-25.083-25.083-35.769-35.769-22.335-22.335-26.58-26.58-14.588-14.588
Investing Activities:
Investments In Property Plant And Equipment -60.951-60.951-38.211-38.211-57.249-57.249-32.858-32.858-34.51-34.51-22.574-22.574-16.482-16.482-17.391-17.391-5.179-5.179
Acquisitions Net 00000.0310-130.57400000000000
Purchases Of Investments 0000-572.8520-1,869.57700000000000
Sales Maturities Of Investments 0000818.84102,193.36100000000000
Other Investing Activites -271.43-271.43-120.415-120.415112.754112.754130.573130.573-110.729-110.729-416.088-416.088-209.033-209.033-108.218-108.2186.26.2
Investing Cash Flow -332.381-332.381-158.626-158.62655.50555.50597.71697.716-145.238-145.238-438.661-438.661-225.515-225.515-125.609-125.6091.0211.021
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 0000001.05100000000000
Common Stock Repurchased -7.987-7.987-26.838-26.838-0.063-0.063-0.963-0.963-11.36-11.36-4.575-4.575000000
Dividends Paid 000000000000000000
Other Financing Activities 10.79710.79718.58418.5842.5862.586-0.725-0.725-2.082-2.0821,170.8831,170.883238.603238.603172.494172.4940.2750.275
Financing Cash Flow 2.8112.811-8.254-8.2542.5232.523-1.687-1.687-13.442-13.4421,166.3091,166.309238.603238.603172.494172.4940.2750.275
Other Information:
Effect Of Forex Changes On Cash 0.5680.568-1.75-1.752.022.02-1.342-1.3423.1263.126-3.255-3.2550.0240.024-0.283-0.283-0.018-0.018
Net Change In Cash -276.986-276.986-110.148-110.14856.79750.787114.86674.108-180.637-180.637688.624688.624-9.223-9.22320.02220.022-13.309-13.309
Cash At End Of Period -276.986-276.986-110.148-110.1481,410.76250.7871,353.9651,131.1941,057.086-180.637688.624729.73541.111-9.22320.02239.53419.512-13.309